See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Donald Trump
Nintendo
Baseball
Natural Disasters
European Union
Social Media
Republican Party
Taxes
Democratic Party
Trade War
Senate
Published • loading... • Updated

BioNTech Surpasses Q4 Revenue Estimates @themotleyfool #stocks $BNTX $PFE $MRNA

Summary by The Motley Fool
Biopharmaceutical company BioNTech SE (NASDAQ:BNTX) reported fourth-quarter and full-year 2024 earnings on Monday, March 10, that topped analysts' consensus expectations. It reported revenue of 1.19 billion euros, ahead of estimates for 1.14 billion but down nearly 43% from the prior year's quarter. Earnings per share (EPS) stood at 1.08 euros against the expected 0.42 euros, a significant outperformance. This quarter displayed resilience, focus…

2 Articles

All
Left
1
Center
Right
The Motley FoolThe Motley Fool
Lean Left

BioNTech Surpasses Q4 Revenue Estimates @themotleyfool #stocks $BNTX $PFE $MRNA

Biopharmaceutical company BioNTech SE (NASDAQ:BNTX) reported fourth-quarter and full-year 2024 earnings on Monday, March 10, that topped analysts' consensus expectations. It reported revenue of 1.19 billion euros, ahead of estimates for 1.14 billion but down nearly 43% from the prior year's quarter. Earnings per share (EPS) stood at 1.08 euros against the expected 0.42 euros, a significant outperformance. This quarter displayed resilience, focus…

·Alexandria, United States
Read Full Article
japan-pc.jpjapan-pc.jp

The Tumultuous Path of BioNTech: From Vaccine Triumphs to Pioneering Cancer Therapies

BioNTech is transitioning from COVID-19 vaccines to focusing on cancer therapies using mRNA platforms. The company reported a significant earnings decline in 2024, with profits falling but exceeding market expectations. Despite losses, the company reallocated resources to cancer research, aiming for market approval of its first treatment by 2026. BioNTech’s research centers on mRNA applications for immune system-based cancer treatment, targeting…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Monday, March 10, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccines

Vaccines

Coronavirus

Coronavirus

Mainz

Mainz

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal